NO994140L - Farmasöytisk sammensetning for den programerte frigivelse av deksfenfluramin - Google Patents

Farmasöytisk sammensetning for den programerte frigivelse av deksfenfluramin

Info

Publication number
NO994140L
NO994140L NO994140A NO994140A NO994140L NO 994140 L NO994140 L NO 994140L NO 994140 A NO994140 A NO 994140A NO 994140 A NO994140 A NO 994140A NO 994140 L NO994140 L NO 994140L
Authority
NO
Norway
Prior art keywords
dexfenfluramine
pharmaceutical composition
programmed release
programmed
release
Prior art date
Application number
NO994140A
Other languages
English (en)
Other versions
NO994140D0 (no
Inventor
Bruno Huet De Barochez
Claude Dauphant
Patrick Wuthrich
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO994140D0 publication Critical patent/NO994140D0/no
Publication of NO994140L publication Critical patent/NO994140L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO994140A 1997-02-28 1999-08-26 Farmasöytisk sammensetning for den programerte frigivelse av deksfenfluramin NO994140L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702446A FR2760190B1 (fr) 1997-02-28 1997-02-28 Composition pharmaceutique pour la liberation programmee de dexfenfluramine
PCT/FR1998/000377 WO1998037876A1 (fr) 1997-02-28 1998-02-26 Composition pharmaceutique pour la liberation programmee de dexfenfluramine

Publications (2)

Publication Number Publication Date
NO994140D0 NO994140D0 (no) 1999-08-26
NO994140L true NO994140L (no) 1999-10-28

Family

ID=9504315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994140A NO994140L (no) 1997-02-28 1999-08-26 Farmasöytisk sammensetning for den programerte frigivelse av deksfenfluramin

Country Status (14)

Country Link
US (1) US5980952A (no)
EP (1) EP0975339A1 (no)
JP (1) JP2001513100A (no)
CN (1) CN1248913A (no)
AU (1) AU727614B2 (no)
BR (1) BR9807278A (no)
CA (1) CA2280980A1 (no)
FR (1) FR2760190B1 (no)
HU (1) HUP0001234A3 (no)
NO (1) NO994140L (no)
NZ (1) NZ337208A (no)
PL (1) PL335374A1 (no)
WO (1) WO1998037876A1 (no)
ZA (1) ZA981679B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
US7244765B2 (en) * 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738303A (en) * 1952-07-18 1956-03-13 Smith Kline French Lab Sympathomimetic preparation
US3520975A (en) * 1967-11-27 1970-07-21 Robins Co Inc A H Anorexigenic compositions comprising fenfluramine and scopolamine
FR2183546B1 (no) * 1972-05-10 1975-06-20 Servier Lab
US4309445A (en) * 1980-06-16 1982-01-05 Massachusetts Institute Of Technology d-Fenfluramine for modifying feeding behavior
US4452815A (en) * 1980-06-16 1984-06-05 Massachusetts Institute Of Technology Method of utilizing d,l-fenfluramine for modifying feeding behavior
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
US4649161A (en) * 1986-06-16 1987-03-10 Massachusetts Institute Of Technology Method for treating depression with d-fenfluramine
EP0308317A1 (fr) * 1987-09-14 1989-03-22 Sanofi Composition anorexigène à mâcher et son procédé de préparation
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
FR2663539B1 (fr) * 1990-06-22 1994-10-07 Adir Utilisation de la d-fenfluramine pour l'obtention de medicaments destines au traitement des deficiences immunitaires chez le sujet age.
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions
JP3492688B2 (ja) * 1992-10-09 2004-02-03 鐘淵化学工業株式会社 微細な造粒体の製造方法
AU6410394A (en) * 1993-03-17 1994-10-11 Pietr Hitzig Method of treating addictive behaviors
US5502080A (en) * 1994-11-01 1996-03-26 Hitzig; Pietr Combined use of dopamine and serotonin agonists in the treatment of allergic disorders
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine

Also Published As

Publication number Publication date
ZA981679B (en) 1998-08-24
AU727614B2 (en) 2000-12-14
US5980952A (en) 1999-11-09
BR9807278A (pt) 2000-05-23
FR2760190B1 (fr) 1999-04-09
FR2760190A1 (fr) 1998-09-04
AU6734698A (en) 1998-09-18
HUP0001234A3 (en) 2001-07-30
CN1248913A (zh) 2000-03-29
NO994140D0 (no) 1999-08-26
JP2001513100A (ja) 2001-08-28
HUP0001234A2 (hu) 2001-06-28
WO1998037876A1 (fr) 1998-09-03
NZ337208A (en) 2000-08-25
EP0975339A1 (fr) 2000-02-02
PL335374A1 (en) 2000-04-25
CA2280980A1 (fr) 1998-09-03

Similar Documents

Publication Publication Date Title
NO20002443D0 (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
FI972945A (fi) Antigeenien antamiseen soveltuvia koostumuksia
DK0922386T3 (da) Sammensætninger med reguleret frigivelse
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
IS5245A (is) Lyfjablanda úr ómeprasól
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
DK0797991T3 (da) Lægemiddelformulering med forhalet frigivelse
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
ID18352A (id) Komposisi-komposisi farmasi
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
NO20002174L (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO20023937L (no) Fremgangsmåte for fremstilling av substituert tiazolidindion
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
ID18698A (id) Komposisi farmasi
NO993912L (no) FremgangsmÕte for fremstilling av eprosartan
NO993913L (no) FremgangsmÕte for fremstilling av eprosartan
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO994140L (no) Farmasöytisk sammensetning for den programerte frigivelse av deksfenfluramin
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
ITMI962628A0 (it) Composizione farmaceutica
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO982975L (no) FremgangsmÕte for fremstilling av fosfatbundne keramer
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application